Broadcom (BRCM) Shares Rise as JPMorgan Highlights Deal for Semi Sockets in Windows Phone 7 Smartphones
Get Alerts BRCM Hot Sheet
Price: $54.67 --0%
Rating Summary:
15 Buy, 29 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 9 | New: 14
Rating Summary:
15 Buy, 29 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 9 | New: 14
Join SI Premium – FREE
Shares of Broadcom (Nasdaq: BRCM) are outperforming the broader stock market Tuesday morning following an earlier bullish note from JPMorgan's Harlan Sur. The stock last traded at $34.95, up 1.3 percent from Monday's close.
Sur points to recent checks which suggest Broadcom has secured the connectivity semi sockets for new Windows Phone 7-based smartphones. The analyst believes the news is significant as Broadcom hasn't historically been the primary connectivity supplier for Nokia's smartphones.
The JPMorgan analyst predicts the development could add $200-$300 million in incremental sales during 2012 for Broadcom.
The analyst reiterated a Buy rating and $45 price target on the stock. Sur's price target implies potential upside of about 29 percent.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Broadcom.
Sur points to recent checks which suggest Broadcom has secured the connectivity semi sockets for new Windows Phone 7-based smartphones. The analyst believes the news is significant as Broadcom hasn't historically been the primary connectivity supplier for Nokia's smartphones.
The JPMorgan analyst predicts the development could add $200-$300 million in incremental sales during 2012 for Broadcom.
The analyst reiterated a Buy rating and $45 price target on the stock. Sur's price target implies potential upside of about 29 percent.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Broadcom.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan First Take on Biogen (BIIB)
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
- AGNC Investment Corp (AGNC) PT Lowered to $9.50 at BofA Securities
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!